<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">ZzGsTwJZPHP6TtVMLGpTr6r</article-id>
      <article-id pub-id-type="other">00011</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2009000200011</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(09)09200211</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2009000200011</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tradu&#231;&#227;o e valida&#231;&#227;o do Walking Impairment Questionnaire em brasileiros com claudica&#231;&#227;o intermitente</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ritti-Dias</surname>
            <given-names>Raphael Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gobbo</surname>
            <given-names>Luis Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cucato</surname>
            <given-names>Gabriel Grizzo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wolosker</surname>
            <given-names>Nelson</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jacob Filho</surname>
            <given-names>Wilson</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santar&#233;m</surname>
            <given-names>Jos&#233; Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carvalho</surname>
            <given-names>Celso Ricardo Fernandes</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Forjaz</surname>
            <given-names>Cl&#225;udia L&#250;cia de Moraes</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marucci</surname>
            <given-names>Maria de F&#225;tima Nunes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Sa&#250;de P&#250;blica </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Escola de Educa&#231;&#227;o F&#237;sica e Esporte </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>02</month>
        <year>2009</year>
      </pub-date>
      <volume>92</volume>
      <issue>2</issue>
      <fpage>143</fpage>
      <lpage>149</lpage>
      <history>
        <date date-type="rev-recd">
          <day>08</day>
          <month>08</month>
          <year>2008</year>
        </date>
        <date date-type="received">
          <day>20</day>
          <month>05</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>08</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: O Walking Impairment Questionnaire (WIQ) tem sido utilizado para a obten&#231;&#227;o de informa&#231;&#245;es sobre a percep&#231;&#227;o de locomo&#231;&#227;o dos indiv&#237;duos com claudica&#231;&#227;o intermitente (CI). Entretanto, esse question&#225;rio ainda n&#227;o foi traduzido para o idioma portugu&#234;s, o que limita sua utiliza&#231;&#227;o em amostra brasileira. OBJETIVO: Traduzir e verificar a validade e reprodutibilidade do WIQ em brasileiros com CI. M&#201;TODOS: Participaram deste estudo 42 indiv&#237;duos com CI, diagnosticados pelo &#237;ndice tornozelo-bra&#231;o &lt; 0,90. Ap&#243;s os procedimentos de tradu&#231;&#227;o e retradu&#231;&#227;o do question&#225;rio, realizado por dois tradutores independentes, a validade de constructo do WIQ foi analisada correlacionando os escores do WIQ com os escores do Medical Outcome Study Questionnaire Short Form 36 (SF-36) e com o desempenho em testes de aptid&#227;o f&#237;sica (marcha e de for&#231;a m&#225;xima). A reprodutibilidade foi analisada em duas aplica&#231;&#245;es do WIQ com 7 dias de intervalo. RESULTADOS: Foi encontrada correla&#231;&#227;o significativa entre os dom&#237;nios do WIQ, os dom&#237;nios do SF-36 (capacidade funcional, aspectos f&#237;sicos, dor e aspectos emocionais) e o desempenho nos testes de aptid&#227;o f&#237;sica (marcha e for&#231;a m&#225;xima). Al&#233;m disso, verificaram-se coeficientes de correla&#231;&#227;o intraclasse que variaram de 0,72 a 0,81, e n&#227;o houve diferen&#231;a entre os escores do WIQ entre as duas aplica&#231;&#245;es do question&#225;rio. CONCLUS&#195;O: A vers&#227;o em portugu&#234;s do WIQ &#233; v&#225;lida e reprodut&#237;vel em brasileiros com CI.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Claudica&#231;&#227;o intermitente</kwd>
        <kwd>estudos de valida&#231;&#227;o</kwd>
        <kwd>toler&#226;ncia ao exerc&#237;cio</kwd>
        <kwd>limita&#231;&#227;o da mobilidade</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>06</day>
        <month>04</month>
        <year>2009</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> REABILITA&#199;&#195;O CARDIOVASCULAR</p>
    <p>Tradu&#231;&#227;o e valida&#231;&#227;o do <italic><bold>Walking Impairment Questionnaire</bold></italic> em brasileiros com claudica&#231;&#227;o intermitente</p>
    <p>
      <bold>Raphael Mendes Ritti-Dias<sup>I</sup>; Luis Alberto Gobbo<sup>I</sup>; Gabriel Grizzo Cucato<sup>II</sup>; Nelson Wolosker<sup>III</sup>; Wilson Jacob Filho<sup>III</sup>; Jos&#233; Maria Santar&#233;m<sup>III</sup>; Celso Ricardo Fernandes Carvalho<sup>III</sup>; Cl&#225;udia L&#250;cia de Moraes Forjaz<sup>II</sup>; Maria de F&#225;tima Nunes Marucci<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Faculdade de Sa&#250;de P&#250;blica - USP, SP - Brasil </p>
    <p><sup>II</sup>Escola de Educa&#231;&#227;o F&#237;sica e Esporte - USP, SP - Brasil </p>
    <p><sup>III</sup>Faculdade de Medicina - USP, S&#227;o Paulo, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> O <italic>Walking Impairment Questionnaire</italic> (WIQ) tem sido utilizado para a obten&#231;&#227;o de informa&#231;&#245;es sobre a percep&#231;&#227;o de locomo&#231;&#227;o dos indiv&#237;duos com claudica&#231;&#227;o intermitente (CI). Entretanto, esse question&#225;rio ainda n&#227;o foi traduzido para o idioma portugu&#234;s, o que limita sua utiliza&#231;&#227;o em amostra brasileira. </p>
    <p><bold>OBJETIVO:</bold> Traduzir e verificar a validade e reprodutibilidade do WIQ em brasileiros com CI. </p>
    <p><bold>M&#201;TODOS:</bold> Participaram deste estudo 42 indiv&#237;duos com CI, diagnosticados pelo &#237;ndice tornozelo-bra&#231;o &lt; 0,90. Ap&#243;s os procedimentos de tradu&#231;&#227;o e retradu&#231;&#227;o do question&#225;rio, realizado por dois tradutores independentes, a validade de constructo do WIQ foi analisada correlacionando os escores do WIQ com os escores do <italic>Medical Outcome Study Questionnaire Short Form</italic> 36 (SF-36) e com o desempenho em testes de aptid&#227;o f&#237;sica (marcha e de for&#231;a m&#225;xima). A reprodutibilidade foi analisada em duas aplica&#231;&#245;es do WIQ com 7 dias de intervalo. </p>
    <p><bold>RESULTADOS:</bold> Foi encontrada correla&#231;&#227;o significativa entre os dom&#237;nios do WIQ, os dom&#237;nios do SF-36 (capacidade funcional, aspectos f&#237;sicos, dor e aspectos emocionais) e o desempenho nos testes de aptid&#227;o f&#237;sica (marcha e for&#231;a m&#225;xima). Al&#233;m disso, verificaram-se coeficientes de correla&#231;&#227;o intraclasse que variaram de 0,72 a 0,81, e n&#227;o houve diferen&#231;a entre os escores do WIQ entre as duas aplica&#231;&#245;es do question&#225;rio. </p>
    <p><bold>CONCLUS&#195;O:</bold> A vers&#227;o em portugu&#234;s do WIQ &#233; v&#225;lida e reprodut&#237;vel em brasileiros com CI.</p>
    <p><bold>Palavras-chave:</bold> Claudica&#231;&#227;o intermitente, estudos de valida&#231;&#227;o, toler&#226;ncia ao exerc&#237;cio, limita&#231;&#227;o da mobilidade.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A claudica&#231;&#227;o intermitente (CI), um dos sintomas mais comuns da doen&#231;a arterial perif&#233;rica, &#233; caracterizada por dor, c&#227;ibra ou formigamento nos membros inferiores que ocorrem durante a pr&#225;tica de atividade f&#237;sica e cessam com o repouso<sup>1</sup>. Conseq&#252;entemente, indiv&#237;duos com CI apresentam intoler&#226;ncia ao exerc&#237;cio f&#237;sico<sup>2</sup>.</p>
    <p>A medida da capacidade de marcha tem sido amplamente utilizada para caracterizar a limita&#231;&#227;o funcional imposta pela doen&#231;a e para analisar o efeito de programas de interven&#231;&#227;o. Para tanto, diversos protocolos de marcha, cont&#237;nuos e progressivos<sup>3,4</sup>, espec&#237;ficos para essa popula&#231;&#227;o, podem ser utilizados. Contudo, a realiza&#231;&#227;o de testes de marcha envolve, geralmente, a utiliza&#231;&#227;o de erg&#244;metros, maior custo operacional e a necessidade de acompanhamento por profissional especializado (por tratar-se de teste m&#225;ximo em popula&#231;&#227;o de risco), o que limita sua utiliza&#231;&#227;o em escala populacional. </p>
    <p>Diante dessas dificuldades, o <italic>Walking Impairment Questionnaire </italic>(WIQ)<sup>5</sup> tem sido utilizado, isoladamente ou em conjunto com testes de marcha, para a obten&#231;&#227;o de informa&#231;&#245;es sobre a capacidade de locomo&#231;&#227;o dos indiv&#237;duos com CI. Esse question&#225;rio aborda aspectos referentes ao &#250;ltimo m&#234;s e &#233; composto por tr&#234;s dom&#237;nios: dist&#226;ncia (dist&#226;ncias que o indiv&#237;duo consegue caminhar), velocidade (velocidade que o indiv&#237;duo consegue caminhar) e escadas (quantidade de escadas que o indiv&#237;duo consegue subir). </p>
    <p>Embora o WIQ apresente validade em outros idiomas<sup>6,7</sup>, esse question&#225;rio ainda n&#227;o foi traduzido para o idioma portugu&#234;s, o que limita sua utiliza&#231;&#227;o em brasileiros. Assim, o objetivo deste estudo foi traduzir e verificar a validade e reprodutibilidade do WIQ em amostra brasileira. </p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>
      <bold>Amostra</bold>
    </p>
    <p>Participaram voluntariamente do estudo 42 indiv&#237;duos, de ambos os g&#234;neros, com sintomas de CI h&#225; mais de 6 meses. Como crit&#233;rios de inclus&#227;o ao estudo, os indiv&#237;duos deveriam apresentar est&#225;gio II da doen&#231;a arterial perif&#233;rica, segundo os crit&#233;rios de Fontaine e cols.<sup>8</sup>, e conseguir caminhar, no m&#237;nimo, 2 minutos com velocidade de 3,2 km/h. Foram exclu&#237;dos do estudo indiv&#237;duos que tinham realizado cirurgia de revasculariza&#231;&#227;o ou angioplastia havia menos de um ano e que conseguiam caminhar mais de 20 minutos, ininterruptamente.</p>
    <p>Os indiv&#237;duos foram questionados sobre h&#225;bito de tabagismo e doen&#231;as associadas. O tabagismo foi identificado pelo h&#225;bito atual do consumo de cigarro, charuto ou cachimbo. A presen&#231;a de hipertens&#227;o arterial sist&#234;mica foi identificada por valores de press&#227;o arterial sist&#243;lica <underline>&gt;</underline> 140 mmHg e/ou diast&#243;lica <underline>&gt;</underline> 90 mmHg, ou com pr&#233;vio diagn&#243;stico e utiliza&#231;&#227;o de medicamentos para o tratamento da hipertens&#227;o<sup>9</sup>. O diabetes melito foi definido por valores de glicemia de jejum <underline>&gt;</underline> 126 mg/dl ou com pr&#233;vio diagn&#243;stico e utiliza&#231;&#227;o de medicamentos para o tratamento de diabetes<sup>10</sup>. A presen&#231;a de cardiopatia foi determinada pelo hist&#243;rico de infarto mioc&#225;rdio, isquemia coron&#225;ria, angina ou revasculariza&#231;&#227;o coron&#225;ria.</p>
    <p>De acordo com a Resolu&#231;&#227;o n&#186; 196 de 1996, estabelecida pelo Conselho Nacional de Sa&#250;de, todos os indiv&#237;duos foram devidamente esclarecidos sobre os objetivos e procedimentos do estudo, e, posteriormente, aqueles que concordaram em participar assinaram o termo de consentimento livre e esclarecido. Este estudo foi aprovado pelo Comit&#234; de &#201;tica em Pesquisa com Seres Humanos da institui&#231;&#227;o em que o trabalho foi desenvolvido, Processo n&#186; 1.370, em 14 de dezembro de 2005.</p>
    <p>
      <bold>Tradu&#231;&#227;o do WIQ</bold>
    </p>
    <p>A tradu&#231;&#227;o do WIQ foi feita por um profissional da &#225;rea de letras, especialista em tradu&#231;&#227;o, com l&#237;ngua materna portuguesa, flu&#234;ncia na l&#237;ngua inglesa, e experi&#234;ncia em tradu&#231;&#227;o de artigos na &#225;rea m&#233;dica. O tradutor foi orientado sobre a proposta do estudo e popula&#231;&#227;o-alvo em que o question&#225;rio seria utilizado. Al&#233;m disso, o tradutor foi orientado a realizar a tradu&#231;&#227;o sem&#226;ntica, e n&#227;o apenas literal, e que procurasse utilizar palavras que produzissem o mesmo impacto no nosso contexto cultural, visando &#224; reprodu&#231;&#227;o de uma mesma resposta emocional. </p>
    <p>Em posse da vers&#227;o traduzida do question&#225;rio, realizou-se uma etapa de testes em que foi avaliada a compreens&#227;o do question&#225;rio pelos indiv&#237;duos com CI. Para tanto, uma amostra adicional (que n&#227;o participou do processo de valida&#231;&#227;o e reprodutibilidade) composta por 50 indiv&#237;duos com CI foi selecionada. Nessa etapa, solicitou-se aos indiv&#237;duos com CI que comentassem as quest&#245;es do question&#225;rio, apontando dificuldades e sugerindo termos de mais f&#225;cil compreens&#227;o. Em posse das sugest&#245;es dos indiv&#237;duos, o question&#225;rio foi reanalisado por um profissional da &#225;rea da sa&#250;de, que fez pequenas altera&#231;&#245;es com o objetivo de melhorar a compreens&#227;o do question&#225;rio.</p>
    <p>Ap&#243;s as altera&#231;&#245;es, o question&#225;rio foi ent&#227;o retrovertido de forma independente por um tradutor bil&#237;ng&#252;e, diferente do que fez a primeira tradu&#231;&#227;o. Da mesma forma, o tradutor da retrovers&#227;o tinha forma&#231;&#227;o em letras, com l&#237;ngua materna portuguesa, flu&#234;ncia na l&#237;ngua inglesa e experi&#234;ncia tanto em tradu&#231;&#227;o como em vers&#227;o de textos em l&#237;ngua inglesa. Vale ressaltar que o tradutor respons&#225;vel pela retrovers&#227;o n&#227;o tinha conhecimento da vers&#227;o original em ingl&#234;s do WIQ. </p>
    <p>As vers&#245;es e retrovers&#245;es foram, ent&#227;o, apreciadas pelos autores, por meio da compara&#231;&#227;o com o texto original para corre&#231;&#227;o de discrep&#226;ncias e elabora&#231;&#227;o de uma vers&#227;o de consenso. Para compor essa vers&#227;o, tomou-se cuidado para que se resguardassem as equival&#234;ncias sem&#226;nticas (palavras com mesmo significado) e idiom&#225;ticas (equival&#234;ncia de g&#237;rias e express&#245;es coloquiais), apresentando vocabul&#225;rio simples e direto (<xref ref-type="app" rid="anx01">Anexo 1</xref>). </p>
    <p>
      <bold>Valida&#231;&#227;o do WIQ</bold>
    </p>
    <p>Para an&#225;lise da validade de constructo, os dados obtidos nos tr&#234;s dom&#237;nios do WIQ (dist&#226;ncia, velocidade e escadas) foram comparados com os dados obtidos com o question&#225;rio <italic>Medical Outcome Study Short</italic>-Form 36 (SF-36) e com o desempenho nos testes de marcha e de for&#231;a m&#225;xima. </p>
    <p>Os dados do WIQ foram obtidos por meio de entrevistas, realizadas por &#250;nico avaliador. Para cada dom&#237;nio do WIQ, calcularam-se os escores que variam de 0 a 100: o escore zero representa incapacidade e o 100 indica total capacidade.</p>
    <p>Os dados do SF-36 foram obtidos por meio de entrevistas, realizadas por &#250;nico avaliador. Para cada um dos dom&#237;nios do SF (capacidade funcional, aspectos f&#237;sicos, dor, estado geral de sa&#250;de, vitalidade, aspectos sociais, aspectos emocionais e sa&#250;de mental), calcularam-se os escores que variam de 0 a 100: o escore zero corresponde ao pior estado de sa&#250;de e o 100 ao melhor estado de sa&#250;de. </p>
    <p>O teste de esfor&#231;o foi realizado por meio de teste ergoespirom&#233;trico m&#225;ximo em esteira ergom&#233;trica (Inbrasport modelo ATL). Para tanto, foi utilizado o protocolo escalonado, espec&#237;fico para indiv&#237;duos com CI, com velocidade constante de 3,2 km/h, e incrementos de dois graus de inclina&#231;&#227;o a cada 2 minutos at&#233; a exaust&#227;o<sup>11</sup>. </p>
    <p>Durante o teste, o consumo de oxig&#234;nio foi continuamente medido a cada ciclo respirat&#243;rio por um analisador de gases computadorizado (MGC &#150; CP2D). O consumo pico de oxig&#234;nio (VO<sub>2</sub>pico) foi estabelecido pelo valor mais alto obtido durante o esfor&#231;o, em m&#233;dias de 60 segundos. O indiv&#237;duo foi instru&#237;do a relatar o momento que iniciava a dor no membro inferior, ou seja, a dist&#226;ncia de claudica&#231;&#227;o (DC). Anotou-se tamb&#233;m a dist&#226;ncia total de marcha (DTM), que corresponde &#224; m&#225;xima dist&#226;ncia que o indiv&#237;duo conseguiu caminhar.</p>
    <p>A for&#231;a muscular foi mensurada pelo teste de uma repeti&#231;&#227;o m&#225;xima (1-RM). O teste de 1-RM foi realizado unilateralmente no exerc&#237;cio extens&#227;o de joelhos em ambos os membros. A sess&#227;o de teste teve in&#237;cio com a realiza&#231;&#227;o de aquecimento (10 repeti&#231;&#245;es), com aproximadamente 50% da carga estimada para a primeira tentativa no teste de 1-RM. Os indiv&#237;duos deveriam realizar o movimento de extens&#227;o de joelho at&#233; alcan&#231;ar uma marca que correspondia a 85&#186; de amplitude do movimento. Esse procedimento foi repetido at&#233; que fosse obtida a carga referente a 1-RM. </p>
    <p>Para an&#225;lise dos dados, a for&#231;a foi classificada de acordo com a gravidade da doen&#231;a em cada perna. Assim, a for&#231;a da perna com menor &#237;ndice tornozelo-bra&#231;o (ITB) e a for&#231;a da perna com maior ITB foram analisadas separadamente.</p>
    <p>
      <bold>Reprodutibilidade do WIQ</bold>
    </p>
    <p>Para an&#225;lise da reprodutibilidade do WIQ, entrevistaram-se 21 indiv&#237;duos que compunham uma subamostra em dois momentos: momento 1 e momento 2, intervalados por 7 dias. Nos dois momentos, as entrevistas foram realizadas pelo mesmo avaliador.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Para a an&#225;lise da associa&#231;&#227;o entre os tr&#234;s dom&#237;nios do WIQ com os oito dom&#237;nios do SF-36, as DC e DTM, o VO<sub>2</sub>pico e a for&#231;a m&#225;xima, utilizou-se coeficiente de correla&#231;&#227;o de Spearman. </p>
    <p>O coeficiente de correla&#231;&#227;o intraclasse foi utilizado para verificar a correla&#231;&#227;o entre ao escores do WIQ nos momentos 1 e 2. O teste de Wilcoxon foi utilizado para verificar a exist&#234;ncia de diferen&#231;as entre os escores nos tr&#234;s dom&#237;nios do WIQ, entre os momentos 1 e 2.</p>
    <p>Para todas as an&#225;lises, o n&#237;vel de signific&#226;ncia adotado foi de p&lt;0,05.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Na <xref ref-type="table" rid="tab01">tabela 1</xref>, s&#227;o apresentadas as caracter&#237;sticas gerais da amostra. A maioria da amostra foi composta por indiv&#237;duos do g&#234;nero masculino, com excesso de peso, n&#227;o-tabagistas, hipertensos, n&#227;o-diab&#233;ticos e n&#227;o-cardiopatas. </p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt01.jpg"/></table-wrap>
    <p>Na <xref ref-type="table" rid="tab02">tabela 2</xref>, apresentam-se os coeficientes de correla&#231;&#227;o de Spearman entre os tr&#234;s dom&#237;nios do WIQ com os dom&#237;nios do SF-36. Os tr&#234;s dom&#237;nios do WIQ apresentaram correla&#231;&#227;o significativa com os dom&#237;nios da capacidade funcional e da dor do SF-36 (de 0,33 a 0,54). Os dom&#237;nios da velocidade e das escadas do WIQ tamb&#233;m apresentaram correla&#231;&#227;o significativa com os dom&#237;nios dos aspectos f&#237;sicos (apenas para o dom&#237;nio das escadas) e dos aspectos emocionais do SF-36.</p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt02.jpg"/></table-wrap>
    <p>Na <xref ref-type="table" rid="tab03">tabela 3</xref>, s&#227;o apresentados os coeficientes de correla&#231;&#227;o entre os tr&#234;s dom&#237;nios do WIQ com as vari&#225;veis do teste de esfor&#231;o e da for&#231;a m&#225;xima. Os tr&#234;s dom&#237;nios do WIQ apresentaram correla&#231;&#227;o significativa com a DC, o VO<sub>2</sub> pico e a for&#231;a muscular dos dois membros (de 0,32 a 0,47). Os dom&#237;nios da dist&#226;ncia e das escadas tamb&#233;m apresentaram correla&#231;&#227;o significativa com a DTM (de 0,34 a 0,35).</p>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt03.jpg"/></table-wrap>
    <p>Na <xref ref-type="table" rid="tab04">tabela 4</xref>, constam os dados referentes &#224; reprodutibilidade do WIQ. Foram observados coeficientes de correla&#231;&#227;o intraclasse significativos entre os momentos 1 e 2 que variaram de 0,72 a 0,81 para os tr&#234;s dom&#237;nios do WIQ. Al&#233;m disso, n&#227;o se observaram diferen&#231;as significativas nos escores dos tr&#234;s dom&#237;nios do WIQ entre os momentos 1 e 2.</p>
    <table-wrap id="tab04">
      <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt04.jpg"/></table-wrap>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O objetivo deste estudo foi traduzir e verificar a validade e reprodutibilidade do WIQ em amostra brasileira. Os resultados encontrados indicaram que a vers&#227;o em portugu&#234;s do WIQ apresentou validade e reprodutibilidade em amostra de brasileiros.</p>
    <p> O WIQ, em suas vers&#245;es em l&#237;nguas espanhola<sup>6</sup> e inglesa<sup>5</sup>, vem sendo amplamente utilizado para avalia&#231;&#245;es das limita&#231;&#245;es de locomo&#231;&#227;o de indiv&#237;duos com CI, sendo inclusive validado nesses idiomas<sup>6,7</sup>. Todavia, esse question&#225;rio tem sido pouco utilizado no Brasil, por causa da inexist&#234;ncia de vers&#227;o em portugu&#234;s e em raz&#227;o da falta de valida&#231;&#227;o em amostra nacional.</p>
    <p>Para a tradu&#231;&#227;o do WIQ, observaram-se dificuldades no entendimento de algumas quest&#245;es, principalmente relacionadas &#224; quarta parte, referentes ao dom&#237;nio das escadas. As dificuldades apresentadas no dom&#237;nio das escadas estavam relacionadas &#224; defini&#231;&#227;o do n&#250;mero de degraus, que correspondia a "um lance de escada". Sobre esse ponto, foram contatados os elaboradores da vers&#227;o original do question&#225;rio que esclareceram que "um lance de escada" equivale a oito degraus. Assim, para minimizar as d&#250;vidas e melhorar a compreens&#227;o do question&#225;rio, incluiu-se o n&#250;mero de degraus para cada pergunta dessa se&#231;&#227;o.</p>
    <p>A validade da vers&#227;o traduzida do WIQ em amostra brasileira foi feita por meio da validade de constructo, a qual est&#225; presente quando uma medida se correlaciona com uma vari&#225;vel de acordo com a teoria. Para tanto, dois aspectos s&#227;o considerados: a validade convergente e a validade discriminante<sup>12</sup>. A validade convergente refere-se a quanto dois instrumentos que se prop&#245;em a medir o mesmo constructo apresentam resultados semelhantes. Em contrapartida, a validade discriminante refere-se a quanto dois m&#233;todos que medem constructos diferentes n&#227;o apresentam resultados semelhantes. </p>
    <p>Dessa forma, no presente estudo, a validade de construto foi determinada comparando os escores dos tr&#234;s dom&#237;nios do WIQ com os escores do SF-36, e com o desempenho nos testes de marcha e de for&#231;a m&#225;xima. Assim, seguindo o pressuposto te&#243;rico, seria esperado que os tr&#234;s dom&#237;nios do WIQ apresentassem correla&#231;&#227;o com os dom&#237;nios relacionados &#224; sa&#250;de f&#237;sica do SF-36 e com o desempenho nos testes de marcha e for&#231;a musculares. Esperava-se que o WIQ n&#227;o apresentasse correla&#231;&#227;o com os dom&#237;nios referentes aos aspectos emocionais, especialmente com o dom&#237;nio da sa&#250;de mental do SF-36.</p>
    <p>Os resultados deste estudo confirmaram a validade convergente. Foi observada correla&#231;&#227;o significativa entre os dom&#237;nios do WIQ com os dom&#237;nios relacionados &#224; sa&#250;de f&#237;sica do SF-36 e com o desempenho nos testes de aptid&#227;o f&#237;sica. </p>
    <p>Tendo em vista que uma das principais conseq&#252;&#234;ncias da doen&#231;a arterial perif&#233;rica &#233; a diminui&#231;&#227;o da capacidade para realiza&#231;&#227;o das atividades cotidianas, em raz&#227;o da dor durante a caminhada, seria esperado que os dom&#237;nios da capacidade funcional, aspectos f&#237;sicos e dor do SF-36 apresentassem correla&#231;&#227;o com os dom&#237;nios do WIQ. Esses resultados corroboram os resultados de Collins e cols.<sup>6</sup> que, ao validarem a vers&#227;o espanhola do WIQ, observaram que os maiores coeficientes de correla&#231;&#227;o entre os dom&#237;nios do WIQ e os do SF-36 ocorreram com esses tr&#234;s dom&#237;nios. Da mesma forma, a rela&#231;&#227;o entre o WIQ e o desempenho no teste de marcha tem sido amplamente verificada na literatura<sup>6,7,13</sup>. Essa rela&#231;&#227;o demonstra que o WIQ pode ser utilizado como indicativo subjetivo para a predi&#231;&#227;o do desempenho no teste de marcha em indiv&#237;duos com CI. Nenhum estudo anterior buscou relacionar a for&#231;a muscular com os dom&#237;nios do WIQ. A inclus&#227;o de teste de for&#231;a foi feita por causa da rela&#231;&#227;o existente entre a for&#231;a e os n&#237;veis de atividade f&#237;sica habitual<sup>14</sup> e a capacidade funcional, sugerindo, portanto, converg&#234;ncia entre essas duas vari&#225;veis<sup>15</sup>. Os resultados encontrados neste estudo confirmaram a rela&#231;&#227;o entre a for&#231;a muscular e a capacidade de locomo&#231;&#227;o dos indiv&#237;duos com CI, demonstrando que a for&#231;a dos membros inferiores parece ter influ&#234;ncia direta na capacidade de locomo&#231;&#227;o dos indiv&#237;duos com CI.</p>
    <p>A aus&#234;ncia de correla&#231;&#227;o significativa entre os escores do WIQ e os do dom&#237;nio da sa&#250;de mental do SF-36 confirma o pressuposto para validade discriminante do WIQ. Todavia, foi observada correla&#231;&#227;o significativa entre o WIQ e o dom&#237;nio dos aspectos emocionais do SF-36, o que, em princ&#237;pio, n&#227;o era esperado. Contudo, esses resultados tamb&#233;m foram observados por outros estudos de valida&#231;&#227;o do WIQ<sup>6,7</sup>, sugerindo que, de alguma forma, as limita&#231;&#245;es de locomo&#231;&#227;o est&#227;o relacionadas com o estado emocional dos indiv&#237;duos com CI. De fato, estudos t&#234;m sugerido que a limita&#231;&#227;o funcional dos indiv&#237;duos com CI est&#225; relacionada com a ocorr&#234;ncia de problemas emocionais, como a depress&#227;o<sup>16,17</sup> e o estresse<sup>18</sup>. </p>
    <p>Para tornar o processo de valida&#231;&#227;o completo, este estudo objetivou tamb&#233;m analisar a reprodutibilidade do WIQ em seus tr&#234;s dom&#237;nios<sup>19</sup>. Foram encontrados coeficientes de correla&#231;&#227;o intraclasse que variaram de 0,72 a 0,81. Esses resultados foram similares aos encontrados por Coyne e cols.<sup>20</sup> que verificaram coeficientes de reprodutibilidade que variaram de 0,58 a 0,82. Al&#233;m disso, n&#227;o houve diferen&#231;a entre as m&#233;dias dos escores nos tr&#234;s dom&#237;nios do WIQ entre a primeira e a segunda medida do WIQ. Esses resultados sugerem que o WIQ &#233; reprodut&#237;vel, atendendo, assim, aos crit&#233;rios para valida&#231;&#227;o do instrumento.</p>
    <p>A principal limita&#231;&#227;o do presente estudo &#233; a representatividade da amostra. Como o Brasil apresenta dimens&#245;es continentais, com popula&#231;&#227;o com diferentes caracter&#237;sticas, tanto demogr&#225;fico-biol&#243;gicas como socioculturais, &#233; poss&#237;vel que a vers&#227;o do WIQ traduzida neste estudo n&#227;o seja v&#225;lida para brasileiros de outras regi&#245;es. Assim, &#233; poss&#237;vel que, para a utiliza&#231;&#227;o do WIQ em algumas regi&#245;es, haja a necessidade de realiza&#231;&#227;o da adapta&#231;&#227;o cultural do question&#225;rio para melhorar sua validade. </p>
    <p>Em suma, o WIQ apresentou validade e reprodutibilidade ap&#243;s sua tradu&#231;&#227;o para o portugu&#234;s em amostra brasileira. Esses resultados sugerem que a vers&#227;o em portugu&#234;s do WIQ pode ser utilizada em brasileiros com CI.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi financiado por Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de S&#227;o Paulo (FAPESP).</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de Doutorado de Raphael Mendes Ritti Dias pela Faculdade de Sa&#250;de P&#250;blica da USP.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Raphael Mendes Ritti-Dias </p>
        <p> Av. Eng. Heitor Ant&#244;nio Eiras Garcia, 79 / 44b &#150; Butant&#227; </p>
        <p> 05588-000 &#150; S&#227;o Paulo, SP - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="rdias@usp.br">rdias@usp.br</email>
        </p>
      </fn>
    </p>
    <p> Artigo recebido em 20/05/08; revisado recebido em 08/08/08; aceito em 13/08/08</p>
    <p/>
    <p>Vers&#227;o em portugu&#234;s do <italic>Walking Impairment Questionnaire</italic></p>
    <p>As seguintes quest&#245;es s&#227;o sobre as raz&#245;es pelas quais voc&#234; teve dificuldade para caminhar no &#250;ltimo m&#234;s. Gostar&#237;amos de saber quanta dificuldade voc&#234; teve para caminhar por causa dos seguintes problemas no &#250;ltimo m&#234;s. Por dificuldade entenda quanta dificuldade voc&#234; teve ou quanto esfor&#231;o voc&#234; fez para caminhar, de acordo com os seguintes problemas.</p>
    <p>
      <graphic xlink:href="1678-4170-abc-92-02-0143-00011-e01.jpg"/></p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Wolosker N, Nakano L, Rosoky RA, Puech-Leao    P. Evaluation of walking capacity over time in 500 patients with intermittent    claudication who underwent clinical treatment. Arch Intern Med. 2003; 163 (19):    2296-300.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of walking capacity over time in 500 patients with intermittent claudication who underwent clinical treatment</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2296</fpage>
          <lpage>300</lpage>
          <issue>19</issue>
          <volume>163</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wolosker</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rosoky</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Puech-Leao</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR,    Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral    arterial disease. Int Angiol. 2007; 26 (2): 81-157.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Inter-society consensus for the management of peripheral arterial disease</article-title>
          <source>Int Angiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>81</fpage>
          <lpage>157</lpage>
          <issue>2</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Norgren</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hiatt</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Dormandy</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Nehler</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Fowkes</surname>
              <given-names>FG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Cachovan M, Rogatti W, Woltering F, Creutzig    A, Diehm C, Heidrich H, et al. Randomized reliability study evaluating constant-load    and graded-exercise treadmill test for intermittent claudication. Angiology.    1999; 50 (3): 193-200.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudication</article-title>
          <source>Angiology</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>193</fpage>
          <lpage>200</lpage>
          <issue>3</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cachovan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rogatti</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Woltering</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Creutzig</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diehm</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heidrich</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Chaudhry H, Holland A, Dormandy J. Comparison    of graded versus constant treadmill test protocols for quantifying intermittent    claudication. Vasc Med. 1997; 2 (2): 93-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of graded versus constant treadmill test protocols for quantifying intermittent claudication</article-title>
          <source>Vasc Med</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>93</fpage>
          <lpage>7</lpage>
          <issue>2</issue>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhry</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Holland</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dormandy</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt    WR. Evaluation of walking impairment by questionnaire in patients with peripheral    arterial disease. J Vasc Med Biol. 1990; 2: 142-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease</article-title>
          <source>J Vasc Med Biol</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>142</fpage>
          <lpage>52</lpage>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Regensteiner</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Steiner</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Panzer</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Hiatt</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Collins TC, Suarez-Almazor M, Petersen NJ,    O'Malley KJ. A Spanish translation of the Walking Impairment Questionnaire was    validated for patients with peripheral arterial disease. J Clin Epidemiol. 2004;    57 (12): 1305-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A Spanish translation of the Walking Impairment Questionnaire was validated for patients with peripheral arterial disease</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1305</fpage>
          <lpage>15</lpage>
          <issue>12</issue>
          <volume>57</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Collins</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Suarez-Almazor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>O'Malley KJ</surname>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. McDermott MM, Liu K, Guralnik JM, Martin GJ,    Criqui MH, Greenland P. Measurement of walking endurance and walking velocity    with questionnaire: validation of the walking impairment questionnaire in men    and women with peripheral arterial disease. J Vasc Surg. 1998; 28 (6): 1072-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease</article-title>
          <source>J Vasc Surg</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1072</fpage>
          <lpage>81</lpage>
          <issue>6</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>McDermott</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Guralnik</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Greenland</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Fontaine R, Kim M, Kieny R. Surgical treatment    of peripheral circulation disorders. Helv Chir Acta. 1954; 21 (5-6): 499-533.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Surgical treatment of peripheral circulation disorders</article-title>
          <source>Helv Chir Acta</source>
          <date>
            <year>1954</year>
          </date>
          <fpage>499</fpage>
          <lpage>533</lpage>
          <issue>5-6</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fontaine</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kieny</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Sociedade Brasileira de Cardiologia. IV Diretrizes    brasileiras de hipertens&#227;o arterial. Arq Bras Cardiol. 2004; 82 (supl    4): 7-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretrizes brasileiras de hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>7</fpage>
          <lpage>22</lpage>
          <volume>82</volume>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Report of the Expert Committee on the Diagnosis    and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20 (7): 1183-97.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1183</fpage>
          <lpage>97</lpage>
          <issue>7</issue>
          <volume>20</volume>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Gardner AW, Skinner JS, Cantwell BW, Smith    LK. Progressive vs single-stage treadmill tests for evaluation of claudication.    Med Sci Sports Exerc. 1991; 23 (4): 402-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Progressive vs single-stage treadmill tests for evaluation of claudication</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>402</fpage>
          <lpage>8</lpage>
          <issue>4</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gardner</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Skinner</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Cantwell</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>LK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Stewart AL, Hays RD, Ware JE Jr. The MOS    short-form general health survey. Reliability and validity in a patient population.    Med Care. 1988; 26 (7): 724-35.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The MOS short-form general health survey: Reliability and validity in a patient population</article-title>
          <source>Med Care</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>724</fpage>
          <lpage>35</lpage>
          <issue>7</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Hays</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Ware Jr</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Myers SA, Johanning JM, Stergiou N, Lynch    TG, Longo GM, Pipinos II. Claudication distances and the Walking Impairment    Questionnaire best describe the ambulatory limitations in patients with symptomatic    peripheral arterial disease. J Vasc Surg. 2008; 47 (3): 550-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease</article-title>
          <source>J Vasc Surg</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>550</fpage>
          <lpage>5</lpage>
          <issue>3</issue>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Myers</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Johanning</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Stergiou</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Longo</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Pipinos</surname>
              <given-names>II</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Atkins LM, Gardner AW. The relationship between    lower extremity functional strength and severity of peripheral arterial disease.    Angiology. 2004; 55 (4): 347-55.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The relationship between lower extremity functional strength and severity of peripheral arterial disease</article-title>
          <source>Angiology</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>347</fpage>
          <lpage>55</lpage>
          <issue>4</issue>
          <volume>55</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Atkins</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>AW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. McDermott MM, Tian L, Ferrucci L, Liu K,    Guralnik JM, Liao Y, et al. Associations between lower extremity ischemia, upper    and lower extremity strength, and functional impairment with peripheral arterial    disease. J Am Geriatr Soc. 2008; 56: 724-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease</article-title>
          <source>J Am Geriatr Soc</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>724</fpage>
          <lpage>9</lpage>
          <volume>56</volume>
          <person-group person-group-type="author">
            <name>
              <surname>McDermott</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ferrucci</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Guralnik</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Smolderen KG, Aquarius AE, de Vries J, Smith    OR, Hamming JF, Denollet J. Depressive symptoms in peripheral arterial disease:    a follow-up study on prevalence, stability, and risk factors. J Affect Disord.    2008 (in press).</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors</article-title>
          <source>J Affect Disord.</source>
          <date>
            <year>2008</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Smolderen</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Aquarius</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Vries</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>OR</given-names>
            </name>
            <name>
              <surname>Hamming</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Denollet</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Wong SY, Woo J, Hong AW, Leung JC, Leung    PC. Clinically relevant depressive symptoms and peripheral arterial disease    in elderly men and women: results from a large cohort study in Southern China.    J Psychosom Res. 2007; 63 (5): 471-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinically relevant depressive symptoms and peripheral arterial disease in elderly men and women: results from a large cohort study in Southern China</article-title>
          <source>J Psychosom Res</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>471</fpage>
          <lpage>6</lpage>
          <issue>5</issue>
          <volume>63</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Aquarius AE, De Vries J, Henegouwen DP, Hamming    JF. Clinical indicators and psychosocial aspects in peripheral arterial disease.    Arch Surg. 2006; 141 (2): 161-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical indicators and psychosocial aspects in peripheral arterial disease</article-title>
          <source>Arch Surg</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>161</fpage>
          <lpage>6</lpage>
          <issue>2</issue>
          <volume>141</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aquarius</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>De Vries</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Henegouwen</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Hamming</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Khan KS, Chien PF. Evaluation of a clinical    test. I: assessment of reliability. BJOG. 2001; 108 (6): 562-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of a clinical test. I: assessment of reliability</article-title>
          <source>BJOG</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>562</fpage>
          <lpage>7</lpage>
          <issue>6</issue>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Coyne KS, Margolis MK, Gilchrist KA, Grandy    SP, Hiatt WR, Ratchford A, et al. Evaluating effects of method of administration    on Walking Impairment Questionnaire. J Vasc Surg. 2003; 38 (2): 296-304.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluating effects of method of administration on Walking Impairment Questionnaire</article-title>
          <source>J Vasc Surg</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>296</fpage>
          <lpage>304</lpage>
          <issue>2</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Coyne</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Gilchrist</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Grandy</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Hiatt</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Ratchford</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
    <app-group>
      <app id="anx01">
        <label>Anexo 1</label>
        <title> </title>
      </app>
    </app-group>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Translation and validation of the walking impairment questionnaire in Brazilian subjects with intermittent claudication</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The Walking Impairment Questionnaire (WIQ) has been used to evaluate walking impairment in subjects with intermittent claudication (IC). However, this questionnaire has yet to be translated to Brazilian Portuguese, which limits its use in Brazilian subjects. OBJECTIVE: To translate and analyze the validity and reliability of WIQ in Brazilian subjects with IC. METHODS: Forty-two patients with IC, determined by the ankle-brachial index &lt; 0.90, participated in the study. After translation and re-translation, carried out by two independent translators, the construct validity of the WIQ was analyzed by correlating the WIQ scores with the Medical Outcome Study Questionnaire Short Form 36 (SF-36) scores and the physical fitness performance (treadmill and strength tests). The reliability was analyzed with a 7-day interval between two questionnaire applications. RESULTS: Significant correlations between the WIQ domains and the SF-36 (functional capacity, physical aspects, bodily pain and emotional aspects) and physical fitness performance (treadmill and strength tests) were observed. Moreover, the intraclass coefficient correlation ranged from 0.72 to 0.81, and there were no differences in WIQ scores between the two questionnaire applications. CONCLUSION: The Brazilian Portuguese version of the WIQ is valid and reliable to be used in Brazilian subjects with IC.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Intermittent claudication</kwd>
        <kwd>validation studies</kwd>
        <kwd>exercise tolerance</kwd>
        <kwd>mobility limitation</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p><undefined id="tx-body2"/>Translation and validation of the walking impairment questionnaire in Brazilian subjects with intermittent claudication</p>
      <p>
        <bold>Raphael Mendes Ritti-Dias<sup>I</sup>; Luis Alberto Gobbo<sup>I</sup>; Gabriel Grizzo Cucato<sup>II</sup>; Nelson Wolosker<sup>III</sup>; Wilson Jacob Filho<sup>III</sup>; Jos&#233; Maria Santar&#233;m<sup>III</sup>; Celso Ricardo Fernandes Carvalho<sup>III</sup>; Cl&#225;udia L&#250;cia de Moraes Forjaz<sup>II</sup>; Maria de F&#225;tima Nunes Marucci<sup>I</sup></bold>
      </p>
      <p><sup>I</sup>Faculdade de Sa&#250;de P&#250;blica - USP</p>
      <p><sup>II</sup>Escola de Educa&#231;&#227;o F&#237;sica e Esporte - USP</p>
      <p><sup>II</sup>Faculdade de Medicina - USP, S&#227;o Paulo, SP - Brazil</p>
      <p> Mailing address</p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>BACKGROUND:</bold> The Walking Impairment Questionnaire (WIQ) has been used to evaluate walking impairment in subjects with intermittent claudication (IC). However, this questionnaire has yet to be translated to Brazilian Portuguese, which limits its use in Brazilian subjects.</p>
      <p><bold>OBJECTIVE:</bold> To translate and analyze the validity and reliability of WIQ in Brazilian subjects with IC.</p>
      <p><bold>METHODS: </bold> Forty-two patients with IC, determined by the ankle-brachial index &lt; 0.90, participated in the study. After translation and re-translation, carried out by two independent translators, the construct validity of the WIQ was analyzed by correlating the WIQ scores with the Medical Outcome Study Questionnaire Short Form 36 (SF-36) scores and the physical fitness performance (treadmill and strength tests). The reliability was analyzed with a 7-day interval between two questionnaire applications.</p>
      <p><bold>RESULTS: </bold> Significant correlations between the WIQ domains and the SF-36 (functional capacity, physical aspects, bodily pain and emotional aspects) and physical fitness performance (treadmill and strength tests) were observed. Moreover, the intraclass coefficient correlation ranged from 0.72 to 0.81, and there were no differences in WIQ scores between the two questionnaire applications.</p>
      <p><bold>CONCLUSION:</bold> The Brazilian Portuguese version of the WIQ is valid and reliable to be used in Brazilian subjects with IC.</p>
      <p><bold>Key Words: </bold>Intermittent claudication; validation studies; exercise tolerance; mobility limitation.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The intermittent claudication (IC), one of the most common symptoms of peripheral arterial disease, is characterized by pain, spasm or numbness in the lower limbs that occur during the practice of physical activity and that cease with rest<sup>1</sup>. Consequently, individuals with IC present intolerance to physical exercise<sup>2</sup>. </p>
      <p>The measurement of the walking capacity has been largely used to characterize the functional limitation caused by the disease and to analyze the effect of intervention programs. In order to do that, several continuous and progressive walking protocols<sup>3,4</sup>, specific for this population, can be used. However, the performance of walking tests generally involves the use of ergometers, higher operational costs and the need for follow-up by a specialized professional (considering that it is a maximal test in an at-risk population), which limits its use in a population scale. </p>
      <p>Considering these difficulties, the Walking Impairment Questionnaire (WIQ)<sup>5</sup> has been used, alone or in combination with walking tests, to obtain information on the ambulation capacity of individuals with IC. This questionnaire addresses aspects regarding the last month and consists of three domains: distance (distances that the individual can walk), velocity (velocity at which the individual can walk) and stairs (number of stairs an individual can climb). </p>
      <p>Although the WIQ has been validated in other languages<sup>6,7</sup>, this questionnaire has not been translated to Brazilian Portuguese, which limits its use in Brazilian subjects. Thus, the objective of the present study was to translate and verify the validity and reliability of the WIQ in a Brazilian sample. </p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>
        <bold>Sample</bold>
      </p>
      <p>A total of 42 individuals of both sexes, with IC symptoms for more than six months, voluntarily participated in the study. The inclusion criteria were: individuals with stage II of peripheral artery disease, according to Fontaine's criteria<sup>8</sup> and being able to walk for at least two minutes at a velocity of 3.2 km/h. Individuals that had undergone revascularization surgery or angioplasty less than one year before and were able to walk more than 20 minutes, uninterruptedly, were excluded from the study.</p>
      <p>The individuals were questioned regarding the habit of smoking and associated diseases. Smoking was identified as the current habit of smoking cigarettes, cigars or a pipe. The presence of systemic arterial hypertension was identified by systolic arterial pressure values <underline>&gt;</underline> 140 mmHg and/or diastolic arterial pressure values <underline>&gt;</underline> 90 mmHg, or with a previous diagnosis and use of anti-hypertensive drugs<sup>9</sup>. Diabetes mellitus was defined as fasting glycemia values <underline>&gt;</underline> 126 mg/dl, or with a previous diagnosis and use of medication for the treatment of diabetes<sup>10</sup>. The presence of cardiopathy was determined by the history of myocardial infarction, coronary ischemia, angina or coronary revascularization.</p>
      <p>According to the decree 196, established by the National Health Council, all individuals were appropriately informed about the objectives and procedures of the study and, subsequently, those who agreed to participate in the study signed the Free and Informed Consent Form. The present study was approved by the Ethics Committee in Research with Human Beings of the institution where it was developed, process #1370 on December 14, 2005.</p>
      <p>
        <bold>Translation of the WIQ</bold>
      </p>
      <p>The translation of the WIQ was carried out by a qualified professional, specialist in translations, whose native language is Brazilian Portuguese, fluent in English and experienced in the translation of manuscripts in the medical area. The translator was informed about the proposal of the study and the target-population to whom the questionnaire would be applied. Additionally, the translator was advised to carry out a semantic translation and not just a literal one, as well as to use words that would cause the same impact in our cultural context, aiming at the reproduction of the same emotional response. </p>
      <p>After the translation of the questionnaire, the test phase was carried out, which evaluated the comprehension of the questionnaire by the individuals with IC. In order to do that, an additional sample (that did not participate in the process of validation and reliability), consisting of 50 individuals with IC, was selected. At this phase, the individuals with IC were asked to comment on questionnaire questions, pointing out difficulties and suggesting terms that would be easier to understand. Taking into account the suggestions made by the individuals, the questionnaire was then re-analyzed by a healthcare professional, who made small alterations with the objective of improving the questionnaire comprehension. </p>
      <p>After the alterations, the questionnaire underwent back-translation to English by a different bilingual translator who, similarly to the first one, was also a qualified professional, specialist in translations, whose native language is Brazilian Portuguese, fluent in English and experienced in the translation of manuscripts in the medical area both in Portuguese and English languages. It is important to mention that the translator in charge of the back-translation was blinded to the original English version of the WIQ.</p>
      <p>The translated and back-translated versions were then appraised by the authors, through the comparison with the original text for the correction of discrepancies and creation of a consensus version. In order to create this version, we were careful to preserve the semantic equivalencies (words with the same meaning) and idiomatic ones (equivalent slang and colloquial expressions), presenting a simple and direct vocabulary (Appendix 1).</p>
      <p>
        <bold>Validation of the WIQ</bold>
      </p>
      <p>To analyze the validity of the construct, the data obtained in the three domains of the WIQ (distance, velocity and stairs) were compared with the data obtained with the Medical Outcome Study Short-Form 36 (SF-36) questionnaire, and with the performance at the maximal strength and walking tests. </p>
      <p>The data from the WIQ were obtained through interviews, carried out by a single examiner. The scores were calculated for each domain of the WIQ, which varied from 0-100, with 0 score representing incapacity and 100 representing full capacity. </p>
      <p>The SF-36 data were obtained through interviews, carried out by a single examiner. The scores were calculated for each one of the SF domains (functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects and mental health), which varied from 0-100, with zero corresponding to the worst health status and 100 representing the best health status. </p>
      <p>The stress test was carried out through a maximal ergospirometric test on a treadmill (Inbrasport, ATL model). The stratified protocol was used for the test, which is specific for individuals with IC, with a constant velocity of 3.2 km/h and increased by 2 degrees of inclination every two minutes until the patient reached exhaustion<sup>11</sup>. </p>
      <p>During the test, oxygen consumption was continuously measured at every respiratory cycle by a computerized gas analyzer (MGC &#150; CP2D). The peak oxygen consumption (VO<sub>2 </sub>peak) was established as the highest value obtained during the stress test in 60-second means. The individual was instructed to report the moment when the pain started in the lower limb, that is, the claudication distance (distance at which the patient first experiences pain with exertion) (CD). The maximum walking distance (MWD) was also recorded. </p>
      <p>Muscular strength was measured using the one repetition maximum test (1-RM). The 1-RM test was carried out unilaterally during the knee extension exercise in both limbs. The test session started with the warming-up (10 repetitions), with approximately 50% of the estimated load for the first attempt at the 1-RM test. The individuals had to perform the knee extension movement until they reached a mark that corresponded to 85&#186; of range of movement. This procedure was repeated until the load corresponding to 1-RM had been determined. </p>
      <p>For the data analysis, strength was classified according to the severity of the disease in each leg. Thus, the strength in the leg with the lower ankle-brachial index (ABI) and with the higher ABI was analyzed separately. </p>
      <p>
        <bold>Reliability of the WIQ</bold>
      </p>
      <p>To analyze the reliability of the WIQ, a sub-sample, consisting of 21 individuals, was interviewed at two different moments: moment 1 and moment 2, with a seven-day interval. The interviews were carried out by the same examiner at both moments.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>The analysis of the association between the three domains of the WIQ and the eight domains of the SF-36, the CD and the MWD, the VO<sub>2</sub> peak and the maximal strength was carried out using Spearman's coefficient of correlation. </p>
      <p>The intraclass coefficient of correlation was used to verify the correlation between WIQ scores at moment 1 and 2. Wilcoxon's test was used to verify the existence of differences the scores in the three domains of the WIQ between moments 1 and 2. </p>
      <p>The level of significance was set at p&lt;0.05.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p><xref ref-type="table" rid="tab01-body2"><bold>Table 1</bold></xref> shows the general characteristics of the sample. The majority of the sample consisted of male overweight, non-smokers, hypertensive, non-diabetic and non-cardiopathic individuals.</p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt01-en.jpg"/></table-wrap>
      <p><xref ref-type="table" rid="tab02-body2"><bold>Table 2</bold></xref> shows Spearman's coefficients of correlation between the three domains of the WIQ and the domains of the SF-36. The three domains of the WIQ presented a significant correlation with the functional capacity and pain domains of the SF-36 (0.33 and 0.54). The velocity and stair domains of the WIQ also presented a significant correlation with the domains of physical (only for the stair domain) and the emotional aspects of the SF-36. </p>
      <table-wrap id="tab02-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt02-en.jpg"/></table-wrap>
      <p><xref ref-type="table" rid="tab03-body2"><bold>Table 3</bold></xref> shows the coefficients of correlation between the three WIQ domains and the stress test and maximal strength test variables. The three WIQ domains presented a significant correlation with CD, the VO<sub>2</sub> peak and the muscular strength of both limbs (0.32 to 0.47). The distance and stair domains also presented a significant correlation with the MWD (0.34 to 0.35).</p>
      <table-wrap id="tab03-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt03-en.jpg"/></table-wrap>
      <p><xref ref-type="table" rid="tab04-body2"><bold>Table 4 </bold></xref>shows the data related to the reliability of the WIQ. Significant intraclass coefficients of correlation were observed between moments 1 and 2, which varied from 0.72 to 0.81 for the three WIQ domains. Additionally, no statistically significant difference was observed in the scores of the three WIQ domains between moments 1 and 2.</p>
      <table-wrap id="tab04-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt04-en.jpg"/></table-wrap>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The objective of the present study was to translate the WIQ into Brazilian Portuguese and verify its validity and reliability in a Brazilian sample. The results obtained indicated that the Brazilian Portuguese version of the WIQ presented validity and reliability in a sample of Brazilian individuals. </p>
      <p>The WIQ, in its Spanish<sup>6</sup> and English<sup>5</sup> versions, has been largely used to assess the ambulation limitations in individuals with IC and have been validated in these languages<sup>6,7</sup>. However, this questionnaire has been scarcely used in Brazil, due to the inexistence of its Brazilian Portuguese version and the lack of validation in a national sample. </p>
      <p>The translation of the WIQ presented some difficulties regarding the understanding of some questions, especially related to the fourth part, concerning the stair domain. The difficulties presented in the stair domain were related to the definition of the number of steps that corresponded to a "flight of stairs". About this subject, the authors of the original version of the questionnaire were contacted and they elucidated that point by stating that a "flight of stairs" corresponds to eight steps. Thus, to minimize the doubts and improve the comprehension of the questionnaire, the number of steps was added to each question of this section. </p>
      <p>The validity of the translated version of the WIQ in a Brazilian sample was carried out by construct validity. The construct validity is present when a measurement is correlated with a variable according with the theory. For that purpose, two aspects are considered: the convergent validity and the discriminant validity<sup>12</sup>. The convergent validity refers to what extent two tools that propose to carry out the measurement of the same construct present similar results. On the other hand, the discriminant validity refers to what extent two methods that measure different constructs do not present similar results.</p>
      <p>Therefore, in the present study, the construct validity was determined by comparing the scores of the three domains of the WIQ with the SF-36 scores and the performance at the maximal strength and walking tests. </p>
      <p>Thus, following the theoretical presupposed, it would be expected that the three WIQ domains presented a correlation with the domains related to physical health of the SF-36 and with the performance at the muscular strength and walking tests. On the other hand, it would be expected that the WIQ did not present a correlation with the domains concerning the emotional aspects, especially the mental health domain of the SF-36. </p>
      <p>The results of the present study confirmed the convergent validity. A significant correlation between WIQ domains and the domains related to physical health of the SF-36 and the performance at the physical aptitude tests was observed. </p>
      <p>Considering that one of the main consequences of the peripheral arterial disease is the decrease in the capacity to perform activities of daily living due to pain during the walking activity, it would be expected that the domains of functional capacity, physical aspects and pain of the SF-36 presented a correlation with the WIQ domains. These results corroborate the results obtained by Collins et al<sup>6</sup> when validating the Spanish version of the WIQ, who observed that the highest coefficients of correlation between the WIQ and those of the SF-36 occurred with these three domains. </p>
      <p>Similarly, the association between the WIQ and the performance at the walking test has been broadly verified in the literature<sup>6,7,13</sup>. This association shows that the WIQ can be used as a subjective indicative to predict the performance at the walking test in individuals with IC. On the other hand, no previous study tried to correlate muscular strength with the WIQ domains. The inclusion of the strength test was due to the existing association between the strength and the levels of routine physical activity<sup>14</sup> and the functional capacity, thus suggesting a convergence between these two variables<sup>15</sup>. The results found in the present study confirmed the association between muscular strength and the capacity of ambulation of individuals with IC, demonstrating that the lower-limb strength seems to have a direct influence on the capacity of ambulation of individuals with IC. </p>
      <p>The lack of a significant correlation between the WIQ scores and the scores of the mental health domain of the SF-36 confirms the presupposed for the discriminant validity of the WIQ. However, a significant correlation was observed between the WIQ and the emotional aspect domain of the SF-36, which, at first, was not expected. Nevertheless, these results were also observed by other WIQ validation studies<sup>6,7</sup>, suggesting that, somehow, the ambulation limitations are related to the emotional status of the individuals with IC. In fact, studies have suggested that the functional limitation of the individuals with IC is related to the occurrence of emotional problems, such as depression<sup>16,17</sup> and stress<sup>18</sup>. </p>
      <p>For the process of validation to be complete, the present study also aimed at analyzing the reliability of the WIQ in its three domains<sup>19</sup>. Intraclass coefficients of correlation that varied from 0.72 to 0.81 were observed. These results were similar to those found by Coyne et al<sup>20</sup>, who observed coefficients of reliability that varied from 0.58 to 0.82. </p>
      <p>Additionally, there was no difference between the mean scores in three domains of the WIQ between the first and the second assessments. These results suggest that the WIQ is reproducible and thus meets the criteria for tool validation. </p>
      <p>The main limitation of the present study is the sample representativeness. As Brazil is a country of continental dimensions and its population has different characteristics, demographic-biological as well as sociocultural ones, it is possible that the version of the WIQ that was translated in this study is not valid for Brazilians from other regions. Thus, it is possible that, in order to use the WIQ in some regions, the cultural adaptation of the questionnaire might be necessary to improve its validity.</p>
      <p>In conclusion, the WIQ presented validity and reliability in a Brazilian sample, after its translation into Brazilian Portuguese. These results suggest that the Brazilian Portuguese version of the WIQ can be used in Brazilian patients with IC. </p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was partially funded by Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de S&#227;o Paulo (FAPESP).</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of Doctoral submitted by Raphael Mendes Ritti Dias, from Faculdade de Sa&#250;de P&#250;blica da USP.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Traducci&#243;n y validaci&#243;n del Walking Impairment Questionnaire en brasile&#241;os con claudicaci&#243;n intermitente</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: El Walking Impairment Questionnaire (WIQ) se utiliza para la obtenci&#243;n de informaciones sobre la percepci&#243;n de locomoci&#243;n de los individuos con claudicaci&#243;n intermitente (CI). No obstante, este cuestionario a&#250;n no ha sido traducido al portugu&#233;s, lo que limita su utilizaci&#243;n en muestra brasile&#241;a. OBJETIVO: Traducir y verificar la validez y reproducibilidad del WIQ en brasile&#241;os con CI. M&#201;TODOS: Participaron en este estudio 42 individuos con CI, diagnosticados por el &#237;ndice tobillo-brazo &lt; 0,90. Luego de los procedimientos de traducci&#243;n y retraducci&#243;n del cuestionario, realizado por dos traductores independientes, la validez del constructo del WIQ se analiz&#243; al correlacionar los scores del WIQ con los scores del Medical Outcome Study Questionnaire Short Form 36 (SF-36) y con el desempe&#241;o de pruebas de aptitud f&#237;sica (marcha y de fuerza m&#225;xima). La reproducibilidad se analiz&#243; en dos aplicaciones del WIQ con 7 d&#237;as de intervalo. RESULTADOS: Se encontr&#243; correlaci&#243;n significativa entre los dominios del WIQ, los dominios del SF-36 (capacidad funcional, aspectos f&#237;sicos, dolor y aspectos emocionales) y el desempe&#241;o en las pruebas de aptitud f&#237;sica (marcha y fuerza m&#225;xima). Adem&#225;s de ello, se verificaron coeficientes de correlaci&#243;n intraclase que variaron de 0,72 a 0,81, y no hubo diferencia entre los scores del WIQ entre las dos aplicaciones del cuestionario. CONCLUSI&#211;N: La versi&#243;n en portugu&#233;s del WIQ es v&#225;lida y reproducible en brasile&#241;os con CI.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Claudicaci&#243;n intermitente</kwd>
        <kwd>estudios de validaci&#243;n</kwd>
        <kwd>tolerancia al ejercicio</kwd>
        <kwd>limitaci&#243;n de la movilidad</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="tx-body3">
          <label>
            <bold>Traducci&#243;n y validaci&#243;n del <italic>Walking Impairment Questionnaire</italic> en brasile&#241;os con claudicaci&#243;n intermitente</bold>
          </label>
          <p>
            <bold>Raphael Mendes Ritti-Dias<sup>I</sup>; Luis Alberto Gobbo<sup>I</sup>; Gabriel Grizzo Cucato<sup>II</sup>; Nelson Wolosker<sup>III</sup>; Wilson Jacob Filho<sup>III</sup>; Jos&#233; Maria Santar&#233;m<sup>III</sup>; Celso Ricardo Fernandes Carvalho<sup>III</sup>; Cl&#225;udia L&#250;cia de Moraes Forjaz<sup>II</sup>; Maria de F&#225;tima Nunes Marucci<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Faculdade de Sa&#250;de P&#250;blica - USP, S&#227;o Paulo, SP - Brasil</p>
      <p><sup>II</sup>Escola de Educa&#231;&#227;o F&#237;sica e Esporte - USP, S&#227;o Paulo, SP - Brasil</p>
      <p><sup>III</sup>Faculdade de Medicina - USP, S&#227;o Paulo, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> El <italic>Walking Impairment Questionnaire</italic> (WIQ) se utiliza para la obtenci&#243;n de informaciones sobre la percepci&#243;n de locomoci&#243;n de los individuos con claudicaci&#243;n intermitente (CI). No obstante, este cuestionario a&#250;n no ha sido traducido al portugu&#233;s, lo que limita su utilizaci&#243;n en muestra brasile&#241;a.</p>
      <p><bold>OBJETIVO:</bold> Traducir y verificar la validez y reproducibilidad del WIQ en brasile&#241;os con CI.</p>
      <p><bold>M&#201;TODOS:</bold> Participaron en este estudio 42 individuos con CI, diagnosticados por el &#237;ndice tobillo-brazo &lt; 0,90. Luego de los procedimientos de traducci&#243;n y retraducci&#243;n del cuestionario, realizado por dos traductores independientes, la validez del constructo del WIQ se analiz&#243; al correlacionar los scores del WIQ con los scores del <italic>Medical Outcome Study Questionnaire Short Form</italic> 36 (SF-36) y con el desempe&#241;o de pruebas de aptitud f&#237;sica (marcha y de fuerza m&#225;xima). La reproducibilidad se analiz&#243; en dos aplicaciones del WIQ con 7 d&#237;as de intervalo.</p>
      <p><bold>RESULTADOS:</bold> Se encontr&#243; correlaci&#243;n significativa entre los dominios del WIQ, los dominios del SF-36 (capacidad funcional, aspectos f&#237;sicos, dolor y aspectos emocionales) y el desempe&#241;o en las pruebas de aptitud f&#237;sica (marcha y fuerza m&#225;xima). Adem&#225;s de ello, se verificaron coeficientes de correlaci&#243;n intraclase que variaron de 0,72 a 0,81, y no hubo diferencia entre los scores del WIQ entre las dos aplicaciones del cuestionario.</p>
      <p><bold>CONCLUSI&#211;N:</bold> La versi&#243;n en portugu&#233;s del WIQ es v&#225;lida y reproducible en brasile&#241;os con CI.</p>
      <p><bold>Palabras clave:</bold> Claudicaci&#243;n intermitente, estudios de validaci&#243;n, tolerancia al ejercicio, limitaci&#243;n de la movilidad.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La claudicaci&#243;n intermitente (CI), uno de los s&#237;ntomas m&#225;s comunes de la enfermedad arterial perif&#233;rica, se caracteriza por dolor, calambres u hormigueo en los miembros inferiores que ocurren durante la pr&#225;ctica de actividad f&#237;sica y cesan en reposo<sup>1</sup>. En consecuencia, individuos con CI presentan intolerancia al ejercicio f&#237;sico<sup>2</sup>.</p>
      <p>La medida de la capacidad de marcha ha sido ampliamente utilizada para caracterizar la limitaci&#243;n funcional impuesta por la enfermedad y para analizar el efecto de programas de intervenci&#243;n. Para ello, se pueden utilizar diversos protocolos de marcha, continuos y progresivos<sup>3,4</sup>, espec&#237;ficos para esta poblaci&#243;n. No obstante, la realizaci&#243;n de pruebas de marcha implica, generalmente, la utilizaci&#243;n de erg&#243;metros, mayor costo operacional y la necesidad de un seguimiento por parte de profesional especializado (por tratarse de prueba m&#225;xima en poblaci&#243;n de riesgo), lo que limita su uso en escala poblacional. </p>
      <p>Ante esas dificultades, el <italic>Walking impairment Questionnaire</italic> (WIQ)<sup>5</sup> se utiliza, aisladamente o en conjunto con pruebas de marcha, para la obtenci&#243;n de informaciones sobre la capacidad de locomoci&#243;n de los individuos con CI. Este cuestionario aborda aspectos referentes al &#250;ltimo mes y est&#225; compuesto por tres dominios: distancia (distancias que el individuo consigue caminar), velocidad (velocidad que el individuo consigue caminar) y escaleras (cantidad de escaleras que el individuo consigue subir). </p>
      <p>Aunque el WIQ tenga validez en otros idiomas<sup>6,7</sup>, este cuestionario no se tradujo a&#250;n al portugu&#233;s, lo que limita su utilizaci&#243;n en brasile&#241;os. As&#237;, el objetivo de este estudio fue traducirlo y verificar la validez y la reproducibilidad del WIQ en muestra brasile&#241;a. </p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>
        <bold>Muestra</bold>
      </p>
      <p>Participaron voluntariamente del estudio 42 individuos, de ambos sexos, con s&#237;ntomas de CI desde hac&#237;a m&#225;s de 6 meses. Como criterios de inclusi&#243;n al estudio, los individuos deber&#237;an presentar estadio II de la enfermedad arterial perif&#233;rica, seg&#250;n los criterios de Fontaine et al<sup>8</sup>, y lograr caminar, como m&#237;nimo, 2 minutos a una velocidad de 3,2 km/h. Se excluyeron del estudio a los individuos que hab&#237;an realizado cirug&#237;a de revascularizaci&#243;n o angioplastia hac&#237;a menos de un a&#241;o y que lograban caminar m&#225;s de 20 minutos ininterrumpidamente.</p>
      <p>Los individuos fueron cuestionados sobre h&#225;bito de tabaquismo y enfermedades asociadas. El tabaquismo fue identificado por el h&#225;bito actual del consumo de cigarrillos, puros o pipa. La presencia de hipertensi&#243;n arterial sist&#233;mica se identific&#243; por valores de presi&#243;n arterial sist&#243;lica <underline>&gt;</underline> 140 mmHg y/o diast&#243;lica <underline>&gt;</underline> 90 mmHg, o con diagn&#243;stico previo y uso de medicamentos para el tratamiento de hipertensi&#243;n<sup>9</sup>. La diabetes mellitus se defini&#243; por valores de glicemia en ayuno <underline>&gt;</underline> 126 mg/dl o con diagn&#243;stico previo y uso de medicamentos para el tratamiento de diabetes<sup>10</sup>. La presencia de cardiopat&#237;a se determin&#243; por la historia de infarto de miocardio, isquemia coronaria, angina o revascularizaci&#243;n coronaria.</p>
      <p>De acuerdo con la Resoluci&#243;n n&#186; 196 de 1996, establecida por el Consejo Nacional de Salud, todos los individuos fueron debidamente informados sobre los objetivos y procedimientos del estudio, y posteriormente, aquellos que concordaron en participar firmaron el formulario de consentimiento informado. Este estudio fue aprobado por el Comit&#233; de &#201;tica en Investigaci&#243;n con Seres Humanos de la instituci&#243;n donde se desarroll&#243; el trabajo, Proceso n&#186; 1.370, del 14 de diciembre de 2005.</p>
      <p>
        <bold>Traducci&#243;n del WIQ</bold>
      </p>
      <p>La traducci&#243;n del WIQ la realiz&#243; un profesional del &#225;rea de letras, especialista en traducci&#243;n, con portugu&#233;s como lengua materna, fluente en ingl&#233;s, y experiencia en traducci&#243;n de art&#237;culos en el &#225;rea m&#233;dica. El traductor fue orientado sobre la propuesta del estudio y la poblaci&#243;n blanco en la que se utilizar&#237;a el cuestionario. Adem&#225;s de ello, tambi&#233;n fue orientado a realizar la traducci&#243;n sem&#225;ntica, y no s&#243;lo literal, y a que buscase palabras que produjeran el mismo impacto en nuestro contexto cultural, apuntando a la reproducci&#243;n de una misma respuesta emocional. </p>
      <p>Con la versi&#243;n traducida del cuestionario, se realiz&#243; una etapa de pruebas en la cual se evalu&#243; la comprensi&#243;n del cuestionario por parte de los individuos con CI. Con esa finalidad, se seleccion&#243; una muestra adicional (que no particip&#243; en el proceso de validaci&#243;n y reproducibilidad) compuesta por 50 individuos con CI. En esta etapa, se pidi&#243; a los individuos con CI que comentaran las preguntas del cuestionario, indicando dificultades y sugiriendo t&#233;rminos de m&#225;s f&#225;cil comprensi&#243;n. Con las sugerencias de los individuos, el cuestionario fue reanalizado por un profesional del &#225;rea de la salud, que realiz&#243; peque&#241;as alteraciones con el objetivo de mejorar la comprensi&#243;n del cuestionario.</p>
      <p>Una vez realizadas las alteraciones, el cuestionario fue retraducido de forma independiente por un traductor biling&#252;e, diferente del que hizo la primera traducci&#243;n. De igual forma, el traductor de la retraducci&#243;n era graduado en letras, con portugu&#233;s como lengua materna, fluente en ingl&#233;s y experiencia en la traducci&#243;n de textos de y al ingl&#233;s. Cabe destacar que el traductor responsable por la retraducci&#243;n no ten&#237;a conocimiento de la versi&#243;n original en ingl&#233;s del WIQ. </p>
      <p>Las traducciones y retraducciones fueron entonces apreciadas por los autores, por medio de la comparaci&#243;n con el texto original para la correcci&#243;n de discrepancias y la elaboraci&#243;n de una versi&#243;n de consenso. Para componer esta traducci&#243;n, se tom&#243; cuidado para mantener las equivalencias sem&#225;nticas (palabras con el mismo significado) e idiom&#225;ticas (equivalencia de modismos y expresiones coloquiales), presentando un vocabulario simple y directo (Anexo 1). </p>
      <p>
        <bold>Validaci&#243;n del WIQ</bold>
      </p>
      <p>Para el an&#225;lisis de la validez del constructo, los datos obtenidos en los tres dominios del WIQ (distancia, velocidad y escaleras) se compararon con los datos obtenidos con el cuestionario <italic>Medical Outcome Study Short-Form</italic> 36 (SF-36) y con el desempe&#241;o en las pruebas de marcha y de fuerza m&#225;xima. </p>
      <p>Los datos del WIQ se obtuvieron por medio de entrevistas, realizadas por un &#250;nico evaluador. Para cada dominio del WIQ, se calcularon los scores que var&#237;an de 0 a 100: el score cero representa incapacidad y el 100 indica total capacidad.</p>
      <p>Los datos del SF-36 se obtuvieron por medio de entrevistas, realizadas por un &#250;nico evaluador. Para cada uno de los dominios del SF (capacidad funcional, aspectos f&#237;sicos, dolor, estado general de salud, vitalidad, aspectos sociales, aspectos emocionales y salud mental), se calcularon los scores que var&#237;an de 0 a 100: el score cero corresponde al peor estado de salud y el 100 al mejor estado de salud. </p>
      <p>La prueba de esfuerzo se realiz&#243; por medio de prueba ergoespirom&#233;trica m&#225;xima en estera ergom&#233;trica (Inbrasport modelo ATL). Con esa finalidad, se utiliz&#243; el protocolo escalonado, espec&#237;fico para individuos con CI, con velocidad constante de 3,2 km/h, y aumentos de dos grados de inclinaci&#243;n a cada 2 minutos hasta el agotamiento<sup>11</sup>. </p>
      <p>Durante la prueba, el consumo de ox&#237;geno fue medido continuamente a cada ciclo respiratorio por un analizador de gases computarizado (MGC - CP2D). El pico de consumo de ox&#237;genos (VO<sub>2</sub>pico) se estableci&#243; por el valor m&#225;s alto obtenido durante el esfuerzo, en intervalos de 60 segundos. El individuo fue instruido a relatar el momento en que se iniciaba el dolor en el miembro inferior, es decir, la distancia de claudicaci&#243;n (DC). Se registr&#243; tambi&#233;n la distancia total de marcha (DTM), que corresponde a la m&#225;xima distancia que el individuo logr&#243; caminar.</p>
      <p>La fuerza muscular se midi&#243; por la prueba de una repetici&#243;n m&#225;xima (1-RM). La prueba de 1-RM se realiz&#243; unilateralmente en el ejercicio de extensi&#243;n de rodillas en ambos miembros. La sesi&#243;n de prueba tuvo inicio con la realizaci&#243;n de calentamiento (10 repeticiones), con aproximadamente el 50% de la carga estimada para el primer intento en la prueba de 1-RM. Los individuos deber&#237;an realizar el movimiento de extensi&#243;n de rodilla hasta alcanzar una marca que correspond&#237;a a 85&#186; de amplitud del movimiento. Este procedimiento fue repetido hasta la obtenci&#243;n de la carga referente a 1-RM. </p>
      <p>Para el an&#225;lisis de los datos, la fuerza se clasific&#243; de acuerdo con la gravedad de la enfermedad en cada pierna. As&#237;, la fuerza de la pierna con menor &#237;ndice tobillo-brazo (ITB) y la fuerza de la pierna con mayor ITB fueron analizadas separadamente. </p>
      <p>
        <bold>Reproducibilidad del WIQ</bold>
      </p>
      <p>Para el an&#225;lisis de la reproducibilidad del WIQ, se entrevistaron a 21 individuos que compon&#237;an una sub-muestra en dos momentos: momento 1 y momento 2, intercalados por 7 d&#237;as. En los dos momentos, las entrevistas fueron realizadas por el mismo evaluador.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Para el an&#225;lisis de la asociaci&#243;n entre los tres dominios del WIQ con los ocho dominios del SF-36, las DC y DTM, el VO<sub>2</sub>pico y la fuerza m&#225;xima, se utiliz&#243; el coeficiente de correlaci&#243;n de Spearman. </p>
      <p>El coeficiente de correlaci&#243;n intraclase se utiliz&#243; para verificar la correlaci&#243;n entre los scores del WIQ en los momentos 1 y 2. La prueba de Wilcoxon se utiliz&#243; para verificar la existencia de diferencias entre los scores en los tres dominios del WIQ, entre los momentos 1 y 2.</p>
      <p>Para todos los an&#225;lisis, el nivel de significancia adoptado fue de p&lt;0,05.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>En la <xref ref-type="table" rid="tab01-body3">tabla 1</xref>, se presentan las caracter&#237;sticas generales de la muestra. La mayor&#237;a de la muestra estuvo compuesta por individuos del sexo masculino, con exceso de peso, no tabaquistas, no diab&#233;ticos y no cardi&#243;patas.</p>
      <table-wrap id="tab01-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt01-es.jpg"/></table-wrap>
      <p>En la <xref ref-type="table" rid="tab02-body3">tabla 2</xref>, se presentan los coeficientes de correlaci&#243;n de Spearman entre los tres dominios del WIQ con los dominios del SF-36. Los tres dominios del WIQ presentaron una correlaci&#243;n significativa con los dominios de la capacidad funcional y del dolor del SF-36 (de 0,33 a 0,54). Los dominios de la velocidad y de las escaleras del WIQ tambi&#233;n presentaron correlaci&#243;n significativa con los dominios de los aspectos f&#237;sicos (s&#243;lo para el dominio de las escaleras) y de los aspectos emocionales del SF-36.</p>
      <table-wrap id="tab02-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt02-es.jpg"/></table-wrap>
      <p>En la <xref ref-type="table" rid="tab03-body3">tabla 3</xref> se presentan los coeficientes de correlaci&#243;n entre los tres dominios del WIQ con las variables de la prueba de esfuerzo y de la fuerza m&#225;xima. Los tres dominios del WIQ presentaron una correlaci&#243;n significativa con la DC, el pico de VO<sub>2</sub> y la fuerza muscular de los dos miembros (de 0,32 a 0,47). Los dominios de la distancia y de las escaleras tambi&#233;n presentaron una correlaci&#243;n significativa con la DTM (de 0,34 a 0,35).</p>
      <table-wrap id="tab03-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt03-es.jpg"/></table-wrap>
      <p>En la <xref ref-type="table" rid="tab04-body3">tabla 4</xref>, constan los datos referentes a la reproducibilidad del WIQ. Se observaron coeficientes de correlaci&#243;n intraclase significativos entre los momentos 1 y 2 que variaron de 0,72 a 0,81 para los tres dominios del WIQ. Adem&#225;s de ello, no se observaron diferencias significativas en los scores de los tres dominios del WIQ entre los momentos 1 y 2.</p>
      <table-wrap id="tab04-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0143-00011-gt04-es.jpg"/></table-wrap>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El objetivo de este estudio fue traducir y verificar la validez y reproducibilidad del WIQ en muestra brasile&#241;a. Los resultados encontrados indicaron que la versi&#243;n en portugu&#233;s del WIQ present&#243; validez y reproducibilidad en muestra de brasile&#241;os.</p>
      <p> El WIQ, en sus versiones en espa&#241;ol<sup>6</sup> y en ingl&#233;s<sup>5</sup>, ha sido ampliamente utilizado en la evaluaci&#243;n de las limitaciones de locomoci&#243;n de individuos con CI, estando inclusive validado en estos idiomas<sup>6,7</sup>. Sin embargo, este cuestionario es poco utilizado en Brasil por la inexistencia de una versi&#243;n en portugu&#233;s y en raz&#243;n de la falta de validaci&#243;n en muestra nacional.</p>
      <p>Para la traducci&#243;n del WIQ, se observaron dificultades en la comprensi&#243;n de algunas preguntas, principalmente relacionadas a la cuarta parte, referentes al dominio de las escaleras. Las dificultades presentadas en el dominio de las escaleras estaban relacionadas con la definici&#243;n del n&#250;mero de escalones, que correspond&#237;a a "un tramo de escalera". Sobre este punto, se contactaron los elaboradores de la versi&#243;n original del cuestionario, los que aclararon que "un tramo de escalera" equivale a ocho escalones. As&#237;, para minimizar las dudas y mejorar la comprensi&#243;n del cuestionario, se incluy&#243; el n&#250;mero de escalones para cada pregunta de esta secci&#243;n.</p>
      <p>La validez de la versi&#243;n traducida del WIQ en muestra brasile&#241;a se realiz&#243; por medio de la validez de constructo, la cual est&#225; presente cuando se correlaciona una medida con una variable de acuerdo con la teor&#237;a. Con esa finalidad se consideran dos aspectos: la validez convergente y la validez discriminante<sup>12</sup>. La validez convergente se refiere a la medida en que dos instrumentos que se proponen medir el mismo constructo presentan resultados similares. En contrapartida, la validez discriminante se refiere a la medida en que dos m&#233;todos que miden constructos diferentes no presentan resultados similares. </p>
      <p>De este modo, en el presente estudio, la validez del constructo se determin&#243; compar&#225;ndose los scores de los tres dominios del WIQ con los scores del SF-36, y con el desempe&#241;o en las pruebas de marcha y de fuerza m&#225;xima. As&#237;, sigui&#233;ndose el presupuesto te&#243;rico, se esperaba que los tres dominios del WIQ presentaran correlaci&#243;n con los dominios relacionados a la salud f&#237;sica del SF-36 y con el desempe&#241;o en las pruebas de marcha y fuerza musculares. Se esperaba, asimismo, que el WIQ no presentara correlaci&#243;n con los dominios referentes a los aspectos emocionales, especialmente con el dominio de la salud mental del SF-36.</p>
      <p>Los resultados de este estudio confirmaron la validez convergente. Se observ&#243; una correlaci&#243;n significativa entre los dominios del WIQ con los dominios relacionados a la salud f&#237;sica del SF-36 y con el desempe&#241;o en las pruebas de aptitud f&#237;sica. </p>
      <p>Teniendo en vista que una de las principales consecuencias de la enfermedad arterial perif&#233;rica es la disminuci&#243;n de la capacidad para la realizaci&#243;n de las actividades cotidianas, en raz&#243;n del dolor durante la caminata, se podr&#237;a esperar que los dominios de la capacidad funcional, aspectos f&#237;sicos y dolor del SF-36 presentaran correlaci&#243;n con los dominio del WIQ. Estos resultados corroboran los resultados de Collins et al<sup>6</sup> que, al validar la versi&#243;n espa&#241;ola del WIQ, observaron que los mayores coeficientes de correlaci&#243;n entre los dominios del WIQ y los del SF-36 ocurrieron con esos tres dominios. De igual manera, la relaci&#243;n entre el WIQ y el desempe&#241;o en la prueba de marcha es ampliamente verificada en la literatura<sup>6,7,13</sup>. Esta relaci&#243;n demuestra que el WIQ se puede utilizar como indicativo subjetivo para la predicci&#243;n del desempe&#241;o en la prueba de marcha en individuos con CI. Ning&#250;n estudio anterior busc&#243; relacionar la fuerza muscular con los dominios del WIQ. La inclusi&#243;n de la prueba de fuerza se realiz&#243; por causa de la relaci&#243;n existente entre la fuerza y los niveles de actividad f&#237;sica habitual<sup>14</sup> y la capacidad funcional, sugiriendo, por lo tanto, convergencia entre estas dos variables<sup>15</sup>. Los resultados encontrados en este estudio confirmaron la relaci&#243;n entre la fuerza muscular y la capacidad de locomoci&#243;n de los individuos con CI, demostrando que la fuerza de los miembros inferiores parece tener influencia directa en la capacidad de locomoci&#243;n de los individuos con CI. </p>
      <p>La ausencia de correlaci&#243;n significativa entre los scores del WIQ y los del dominio de la salud mental del SF-36 confirma el presupuesto para validez discriminante del WIQ. No obstante, se observ&#243; una correlaci&#243;n significativa entre el WIQ y el dominio de los aspectos emocionales del SF-36, lo que en principio no era esperado. Aunque estos resultados tambi&#233;n fueron observados por otros estudios de validaci&#243;n del WIQ<sup>6,7</sup>, sugiriendo que, de alguna forma, las limitaciones de locomoci&#243;n est&#225;n relacionadas con el estado emocional de los individuos con CI. De hecho, estudios sugieren que la limitaci&#243;n funcional de los individuos con CI est&#225; relacionada con la ocurrencia de problemas emocionales, como la depresi&#243;n<sup>16,17</sup> y el estr&#233;s<sup>18</sup>. </p>
      <p>Para hacer completo el proceso de validaci&#243;n, este estudio busc&#243; tambi&#233;n analizar la reproducibilidad del WIQ en sus tres dominios<sup>19</sup>. Se encontraron coeficientes de correlaci&#243;n intraclase que variaron de 0,72 a 0,81. Estos resultados fueron similares a los encontrados por Coyne et al<sup>20</sup> que verificaron coeficientes de reproducibilidad que variaron de 0,58 a 0,82. Adem&#225;s de ello, no hubo diferencia entre los promedios de los scores en los tres dominios del WIQ entre la primera y la segunda medida del WIQ. Estos resultados sugieren que el WIQ es reproducible, cumpliendo as&#237; con los criterios para validaci&#243;n del instrumento.</p>
      <p>La principal limitaci&#243;n del presente estudio es la representatividad de la muestra. Como Brasil presenta dimensiones continentales, con poblaci&#243;n con diferentes caracter&#237;sticas, tanto demogr&#225;ficas y biol&#243;gicas como socioculturales, es posible que la versi&#243;n del WIQ traducida en este estudio no sea v&#225;lida para brasile&#241;os de otras regiones. As&#237;, es posible que para la utilizaci&#243;n del WIQ en algunas regiones, haya necesidad de realizarse la adaptaci&#243;n cultural del cuestionario para mejorar su validez. </p>
      <p>En resumen, el WIQ present&#243; validez y reproducibilidad despu&#233;s de su traducci&#243;n para el portugu&#233;s en muestra brasile&#241;a. Estos resultados sugieren que la versi&#243;n en portugu&#233;s del WIQ puede ser utilizada en brasile&#241;os con CI.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuente de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio fue financiado por la Fundaci&#243;n de Amparo a la Investigaci&#243;n del Estado de S&#227;o Paulo (FAPESP, por su sigla en portugu&#233;s).</p>
      <p>
        <bold>V&#237;nculo Acad&#233;mico</bold>
      </p>
      <p>Este art&#237;culo forma parte de la tesis de Doctorado de Raphael Mendes Ritti Dias en la Facultad de Salud P&#250;blica de la USP.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
